Paclitaxel Resistance and Multicellular Spheroid Formation Are Induced by Kallikrein-Related Peptidase 4 in Serous Ovarian Cancer Cells in an Ascites Mimicking Microenvironment

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Characterization of kallikrein-related peptidase 4 glycosylations

(2012) Yasuo Yamakoshi et al.   EUROPEAN JOURNAL OF ORAL SCIENCES

In vitro Mesothelial Clearance Assay that Models the Early Steps of Ovarian Cancer Metastasis

(2012) Rachel A. Davidowitz et al.   Jove-Journal of Visualized Experiments

Kallikreins 5, 6 and 10 Differentially Alter Pathophysiology and Overall Survival in an Ovarian Cancer Xenograft Model

(2011) David Pépin et al.   PLoS One

Ovarian Cancer Spheroids Use Myosin-Generated Force to Clear the Mesothelium

(2011) Marcin P. Iwanicki et al.   Cancer Discovery

Impact of expression differences of kallikrein-related peptidases and of uPA and PAI-1 between primary tumor and omentum metastasis in advanced ovarian cancer

(2010) J. Dorn et al.   ANNALS OF ONCOLOGY

Functional proteomics of kallikrein-related peptidases in ovarian cancer ascites fluid

(2010) Katerina Oikonomopoulou et al.   BIOLOGICAL CHEMISTRY

Kallikrein-Related Peptidase 7 Promotes Multicellular Aggregation via the α5β1Integrin Pathway and Paclitaxel Chemoresistance in Serous Epithelial Ovarian Carcinoma

(2010) Ying Dong et al.   CANCER RESEARCH

Kallikreins on Steroids: Structure, Function, and Hormonal Regulation of Prostate-Specific Antigen and the Extended Kallikrein Locus

(2010) Mitchell G. Lawrence et al.   ENDOCRINE REVIEWS

Review: Practical considerations in ovarian cancer chemotherapy

(2010) Mihaela Cristea et al.   Therapeutic Advances in Medical Oncology

Coexpression of invasive markers (uPA, CD44) and multiple drug-resistance proteins (MDR1, MRP2) is correlated with epithelial ovarian cancer progression

(2009) H Chen et al.   BRITISH JOURNAL OF CANCER

Substrate-Guided Design of a Potent and Selective Kallikrein-Related Peptidase Inhibitor for Kallikrein 4

(2009) Joakim E. Swedberg et al.   CHEMISTRY & BIOLOGY

The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy

(2009) Salvatore Ulisse et al.   CURRENT CANCER DRUG TARGETS

Multicellular spheroids in ovarian cancer metastases: Biology and pathology

(2009) Kristy Shield et al.   GYNECOLOGIC ONCOLOGY

Functional Roles of Human Kallikrein-related Peptidases

(2009) Georgia Sotiropoulou et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Hypoxia induced paclitaxel resistance in human ovarian cancers via hypoxia-inducible factor 1α

(2009) Lei Huang et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Spheroid-based drug screen: considerations and practical approach

(2009) Juergen Friedrich et al.   Nature Protocols

Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression

(2008) Laurie G. Hudson et al.   CLINICAL & EXPERIMENTAL METASTASIS

Compact spheroid formation by ovarian cancer cells is associated with contractile behavior and an invasive phenotype

(2008) Katharine L. Sodek et al.   INTERNATIONAL JOURNAL OF CANCER

Kallikrein-related Peptidase 4 (KLK4) Initiates Intracellular Signaling via Protease-activated Receptors (PARs)

(2008) Andrew J. Ramsay et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Mining the Ovarian Cancer Ascites Proteome for Potential Ovarian Cancer Biomarkers

(2008) Cynthia Kuk et al.   MOLECULAR & CELLULAR PROTEOMICS

Proteomic Analysis of Ovarian Cancer Cells Reveals Dynamic Processes of Protein Secretion and Shedding of Extra-Cellular Domains

(2008) Vitor M. Faça et al.   PLoS One